| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME ACP5 |
[1], [2] |
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 up-regulates the expression of DME ACP5 |
[3] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Polyethylene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01022
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
Polyethylene inhibits the expression of DME ACP5 |
[4] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 10 Xenobiotics
|
| Aluminum oxide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00836
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Aluminum oxide inhibits the expression of DME ACP5 |
[5] |
| Beclomethasone dipropionate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00278
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Beclomethasone dipropionate inhibits the drug-metabolizing activity of DME ACP5 |
[6] |
| Belinostat |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00193
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Belinostat inhibits the expression of DME ACP5 |
[7] |
| Calcitriol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Calcitriol inhibits the drug-metabolizing activity of DME ACP5 |
[8] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin up-regulates the expression of DME ACP5 |
[9] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME ACP5 |
[10] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME ACP5 |
[11] |
| Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME ACP5 |
[12] |
| Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Valproic acid inhibits the expression of DME ACP5 |
[13] |
| Maxacalcitol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00474
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Marketed but not Approved by US FDA |
| DME Modulation |
Maxacalcitol inhibits the drug-metabolizing activity of DME ACP5 |
[14] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| MS-275 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MS-275 up-regulates the expression of DME ACP5 |
[15] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| (+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
(+)-JQ1 inhibits the expression of DME ACP5 |
[16] |
|
|
|
|
|
|